Smartlab Europe

McKesson Launches NEW Drug Spend Intelligence Tool

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Lilly Launches New AI Supercomputer for Drug Development

Eli Lilly has launched what it describes as the...

Advanced Analytical Technologies in Pharma Impurity Testing

Advanced analytical technologies in pharma impurity testing are transforming how trace contaminants are detected, identified, and controlled across the drug lifecycle. With high-resolution instrumentation, automation, and AI-driven insights, the industry is strengthening precision, data integrity, and patient safety to meet increasingly stringent purity standards.

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.
- Advertisement -

McKesson announced the launch of its new Drug Spend Intelligence™ tool. Designed by hospital pharmacists, Drug Spend Intelligence is an easy-to-use online tool that provides the information needed to identify purchase trends, evaluate the impact of price fluctuations, and implement and track clinical initiatives. McKesson’s Drug Spend Intelligence provides access to daily data with rich analytics and customizable reports to help identify potential areas for cost containment to lower drug spend and increase savings.

“The largest expenditure in a hospital pharmacy department is drug purchases. As a result, pharmacy leaders are constantly pressured to reduce their pharmacy’s drug spend and administrative time,” said Yen Nguyen, Pharm.D., director of clinical analytics, McKesson Pharmacy Optimization®. “Managing a hospital or health system’s drug spend requires a clear view into the purchasing history and spending trends, and the ability to turn that information into actionable results.

Drug Spend Intelligence provides access to daily data and robust analytics to help pharmacies gain insight into purchasing trends and variances and to lower drug spend, as well as free pharmacists’ time to focus on medication safety and patient care.”

Latest stories

Related stories

Lilly Launches New AI Supercomputer for Drug Development

Eli Lilly has launched what it describes as the...

Advanced Analytical Technologies in Pharma Impurity Testing

Advanced analytical technologies in pharma impurity testing are transforming how trace contaminants are detected, identified, and controlled across the drug lifecycle. With high-resolution instrumentation, automation, and AI-driven insights, the industry is strengthening precision, data integrity, and patient safety to meet increasingly stringent purity standards.

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.

Quality Risk Management and the Role of Verified Drug Information

Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »